IGC Pharma IGC
NYSE IGC
$0.25 0.00 (-0.08%)
As of: Oct 23, 2026 · 1:36 PM EDT

IGC Pharma (IGC) Gains from Equity Investments (2011 - 2016)

Updated

Analysis

IGC Pharma (IGC) Gains from Equity Investments (2011 - 2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.17 Bn 1,101.76 Bn 19.71 Bn
2 Johnson & Johnson 634.79 Bn 554.65 Bn 17.30 Bn
3 AbbVie 506.40 Bn 479.51 Bn 12.70 Bn
4 Merck 357.93 Bn 312.31 Bn 12.21 Bn
5 Novartis Ag 292.69 Bn 256.68 Bn 11.24 Bn
6 Astrazeneca 265.19 Bn 238.87 Bn 12.86 Bn
7 Amgen 238.22 Bn 193.61 Bn 7.24 Bn
8 Gilead Sciences 195.23 Bn 169.43 Bn 6.22 Bn
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn
10 IGC Pharma 24.30 Mn 21.54 Mn 55,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 139,657.00
Dec 31, 2015 -23,533.00
Sep 30, 2015 -69,037.00
Jun 30, 2015 -47,087.00
Mar 31, 2015 31,360.00
Dec 31, 2014 -43,418.00
Sep 30, 2014 -74,905.00
Jun 30, 2014 -3,150.00
Mar 31, 2014 -227,208.00
Jun 30, 2013 -28,463.00
Dec 31, 2011 -33,588.00
Sep 30, 2011 25,832.00
Jun 30, 2011 36,219.00
API Access

IGC Pharma Gains from Equity Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-equity-investments&ticker=IGC&period=max&api_key=YOUR_API_KEY